NPGCU
PFE icon

Napier Park Global Capital (US)’s Pfizer PFE Stock Holding History

Napier Park Global Capital (US)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-421,600
Closed -$120K – 19
2017
Q4 		$120K Buy
+421,600
New +$14.4M 0.92% 12

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Napier Park Global Capital (US)'s PFE Position: Q3 2019 in Review

Napier Park Global Capital (US) sold out of Pfizer (PFE) in Q3 2019, closing a stake of 29,512 shares — an estimated $1.21M sold.

Napier Park Global Capital (US) first reported a position in PFE in Q2 2019 and held it in 1 quarter. The position peaked at $1.21M in Q2 2019. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Napier Park Global Capital (US) reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
  • Napier Park Global Capital (US) sold 29,512 Pfizer shares in Q3 2019, an estimated $1.21M.
  • Napier Park Global Capital (US) first reported a position in Pfizer in Q2 2019 and held it in 1 quarter.
  • Napier Park Global Capital (US)'s Pfizer position peaked at $1.21M in Q2 2019.
  • 2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Napier Park Global Capital (US)'s 13F filing for Q3 2019, filed 13 Nov 2019.